The Suraksha Diagnostic IPO allotment is expected to be finalized on Wednesday, December 4, 2024. Once the allotment is finalized, you can check the allotment status online on the websites of the registrar, Kfin Technologies, the NSE, and the BSE. The IPO was fully subscribed on the last day of the share sale, November 3, 2024.
The Suraksha Diagnostic IPO opened for subscription on November 29, 2024, and will close today, December 3, 2024. The issue size is ₹846.25 crore, with a price band of ₹420-441 per share. Allotment is expected on December 4, 2024, and the listing will take place on December 6, 2024, on both BSE and NSE.
The Suraksha Diagnostic IPO received an overall subscription of 1.27 times by the third day, December 3, 2024. The retail segment saw a subscription of 0.94 times, while Qualified Institutional Buyers (QIBs) subscribed 1.74 times their allotted shares. Non-Institutional Investors (NIIs) subscribed 1.40 times. The IPO was worth ₹846.25 crore and was completely an offer-for-sale of 19,189,330 equity shares.
As the IPO consisted solely of an OFS, the primary objective was to provide an exit opportunity for existing shareholders. The company does not raise any capital through this offering.
Suraksha Diagnostic (SDL) was established in 2005 and is headquartered in Kolkata. It is a provider of integrated diagnostic services catering to key regions in India, including West Bengal, Bihar, Assam, and Meghalaya. The company offers a comprehensive range of pathology, radiology, and specialised diagnostic solutions. Suraksha Diagnostic also offers pathology and radiology testing solutions through its extensive operational network.